Authors who are interested in presenting their work during the oral or poster presentation session are required to submit an abstract. Please refer to the following guidelines for the abstract submission and oral/poster presentation.
Abstract Submission
-
Please submit an abstract (250 words maximum) summarizing your work, including the background, objectives of the study, methodology, results, conclusion, and keywords (3-6 words). Title, authors’ names, and affiliations are excluded from the word count. Please also indicate which topic/theme (from the following options) your work/presentation would fit the best in your registration form.
Available themes:
-
Pharmacology, Pharmaceutical Chemistry and Biotechnology (Code: PPCP)
-
Pharmaceutical Education, Social and Administrative Pharmacy, and Clinical Pharmacy (Code: PESC)
-
Pharmaceutic and Drug Delivery System (Code: PDDS)
-
Herbal Medicine and Natural Products (Code: HMNP)
-
Cancer Chemoprevention (Code: CCP)
Please strictly use this template (Click Here) when preparing your abstract.
-
Submitted abstracts should be written in English with a quality suitable for publication. The committee may request an abstract revision if the submitted abstract was not written in proper English.
-
The presenting author must be listed as the first author and ensure that all co-authors are aware of the content of the abstract before submission.
-
Each presenter can submit 1 abstract only.
-
The abstract should not contain any table, graph, or image.
Abstract Selection dan Notification of Acceptance
-
The committee will review all submitted abstracts. Notification regarding abstract acceptance and presentation schedule will be sent to the submitting author on Aug 8, 2023
-
The committee reserves the right to change the topic/theme under which the abstract is originally submitted.
-
The presenting author will be invited to complete the registration payment by Aug 15, 2023.